Feed EMBC
EMEmbecta Corp. EMBC · NASDAQ
$6.56 +1.55% (+$0.10)
Depth
- Market cap
- $371.7M
- Enterprise value
- $1.65B
- P/E
- 4.2x
- Forward P/E
- 3.6x
- PEG
- 0.2x
- P/S
- 0.4x
- P/FCF
- 2.3x
- EV/EBITDA
- 6.0x
- ROIC
- 17.9%
- Gross margin
- 59.9%
- Net margin
- 8.6%
- Dividend yield
- 4.88%
- Payout ratio
- 20.7%
- Net debt/EBITDA
- 4.7x
- Beta
- 0.83
- Free float
- 96.7%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Devdatt Kurdikar
Employees
1,850
Headquarters
Parsippany
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Earnings per share fell by 25% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: It earns 18 USD a year on every 100 USD of invested capital.
- What speaks for it: Out of every 100 USD of revenue, 16 USD is left as free cash.
Financial health
Can it carry its debt?
- What to watch: Repaying its net debt would take 4.7 years of operating profit.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number